SEARCH
New ‘safe and effective’ Alzheimer’s drug gets full approval from US regulators
euronews (in English)
2023-07-07
Views
12
Description
Share / Embed
Download This Video
Report
The treatment received conditional approval in January, but received full approval following a review of data from a further 1,800 patient study that showed the drug slowed cognitive decline by 5 months.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x8mciul" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:42
Rise of sharing economy companies challenging tradtional industries and government regulators
00:30
'Tech companies will have to pay a fee to the regulators monitoring their compliance'
01:49
Darwin methane leak ‘covered up’ by gas companies and regulators for nearly 20 years
03:44
Feargal Sharkey: The musician turned campaigner who will not rest until water companies, regulators and minister tackle river pollution
00:05
Read Drugs for Life: How Pharmaceutical Companies Define Our Health (Experimental Futures)
02:25
Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical companies
12:07
Para tugunan ang naging kakulangan sa supply ng mga experimental drugs sa mga ospital, ilang gamot ng pharmaceutical companies ang inaprubahan at binigyan ng lisensya ng FDA
03:41
Pharmaceutical sector - Drug companies bracing for U.S. tariffs
21:50
Glimmer of hope: 3 Indian pharmaceutical companies get DGCI nod for Covid-19 drugs
00:29
[PDF] Drugs for Life: How Pharmaceutical Companies Define Our Health: Experimental Futures
01:36
Coronavirus in Germany: Berlin pressuring EU regulators to speed up jab approval
02:51
In a statement, it wrote that “any allegations of disregard for consumers who need these lifesaving drugs, government officials, regulators or any other of our valued stakeholders are patently false